Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Pencik J, Pham HTT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DNT, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R.

Cell Death Dis. 2019 Aug 13;10(8):605. doi: 10.1038/s41419-019-1853-1.

2.

The Impact of l-Thyroxine Treatment of Donors and Recipients on Postoperative Outcomes After Heart Transplantation.

Holndonner-Kirst E, Nagy A, Czobor NR, Fazekas L, Dohan O, Kertai MD, Lex DJ, Sax B, Hartyanszky I, Merkely B, Gal J, Szekely A.

J Cardiothorac Vasc Anesth. 2019 Jun;33(6):1629-1635. doi: 10.1053/j.jvca.2018.10.024. Epub 2018 Oct 25.

PMID:
30467031
3.

[Evolution of the Hungarian adult heart transplantation program].

Hartyánszky I, Horkay F, Hüttl T, Fazekas L, Pólos M, Daróczi L, Heltai K, Sax B, Becker D, Németh E, Merkely B, Szabolcs Z.

Orv Hetil. 2018 Nov;159(46):1869-1875. doi: 10.1556/650.2018.31299. Hungarian.

PMID:
30450939
4.

Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Jan Pencik, Pham HTT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DNT, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R.

Cell Death Dis. 2018 Jul 23;9(8):800. doi: 10.1038/s41419-018-0773-9.

5.

[Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation].

Szudi L, Székely L, Sápi E, Prodán Z, Szolnoky J, Csomós Á, Nyolczas N, Paulovich E, Németh E, Hartyánszky I, Zima E, Sax B, Bertalan A, Hejjel L, Bogáts G, Babik B, Gombocz K, Szerafin T, Koszta G, Molnár A.

Orv Hetil. 2018 Jun;159(22):870-877. doi: 10.1556/650.2018.31083. Hungarian.

PMID:
29806474
6.

Higher Transaminase Levels in the Postoperative Period After Orthotopic Heart Transplantation Are Associated With Worse Survival.

Holndonner-Kirst E, Nagy A, Czobor NR, Fazekas L, Lex DJ, Sax B, Hartyanszky I, Merkely B, Gal J, Szekely A.

J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1711-1718. doi: 10.1053/j.jvca.2018.01.002. Epub 2018 Jan 5.

PMID:
29433797
7.

Dominance of free wall radial motion in global right ventricular function of heart transplant recipients.

Lakatos BK, Tokodi M, Assabiny A, Tősér Z, Kosztin A, Doronina A, Rácz K, Koritsánszky KB, Berzsenyi V, Németh E, Sax B, Kovács A, Merkely B.

Clin Transplant. 2018 Mar;32(3):e13192. doi: 10.1111/ctr.13192. Epub 2018 Jan 20.

PMID:
29315873
8.

Image Quality of Prospectively ECG-Triggered Coronary CT Angiography in Heart Transplant Recipients.

Bartykowszki A, Kolossváry M, Jermendy ÁL, Karády J, Szilveszter B, Károlyi M, Balogh O, Sax B, Merkely B, Maurovich-Horvat P.

AJR Am J Roentgenol. 2018 Feb;210(2):314-319. doi: 10.2214/AJR.17.18546. Epub 2017 Nov 1.

PMID:
29091000
9.

[Heart transplantation and long-term lvad support cost-effectiveness model].

Szentmihályi I, Barabás JI, Bali Á, Kapus G, Tamás C, Sax B, Németh E, Pólos M, Daróczi L, Kőszegi A, Cao C, Benke K, Kovács PB, Fazekas L, Szabolcs Z, Merkely B, Hartyánszky I.

Magy Seb. 2016 Dec;69(4):186-193. Hungarian.

PMID:
27991023
10.

Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.

Javaheri T, Kazemi Z, Pencik J, Pham HT, Kauer M, Noorizadeh R, Sax B, Nivarthi H, Schlederer M, Maurer B, Hofbauer M, Aryee DN, Wiedner M, Tomazou EM, Logan M, Hartmann C, Tuckermann JP, Kenner L, Mikula M, Dolznig H, Üren A, Richter GH, Grebien F, Kovar H, Moriggl R.

Cell Death Dis. 2016 Oct 13;7(10):e2419. doi: 10.1038/cddis.2016.268. Erratum in: Cell Death Dis. 2018 Jul 23;9(8):800. Retraction in: Cell Death Dis. 2019 Aug 13;10(8):605.

11.

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.

Minas TZ, Surdez D, Javaheri T, Tanaka M, Howarth M, Kang HJ, Han J, Han ZY, Sax B, Kream BE, Hong SH, Çelik H, Tirode F, Tuckermann J, Toretsky JA, Kenner L, Kovar H, Lee S, Sweet-Cordero EA, Nakamura T, Moriggl R, Delattre O, Üren A.

Oncotarget. 2017 May 23;8(21):34141-34163. doi: 10.18632/oncotarget.9388.

12.

Cardiac allograft vasculopathy: optical coherence guided innovative treatment options with the bioresorbable vascular scaffold: proof of concept.

Édes IF, Hajas Á, Sax B, Bartykowszki A, Becker D, Merkely B.

Minerva Cardioangiol. 2016 Aug;64(4):487-93. Epub 2016 May 6. Review.

PMID:
27152623
13.

The European Respiratory Society evaluates its 2013-2018 strategic plan implementation.

Migliori GB, Bel E, Joos G, Elliott M, Rohde G, Holgate ST, Gratziou C, Smyth D, Gaga M, Cordeiro CR, Burghuber OC, Brusselle G, Martin-Burrieza F, Bill W, Sax B, Vestbo J.

Eur Respir J. 2016 Mar;47(3):693-8. doi: 10.1183/13993003.02110-2015. No abstract available.

14.

[Mechanical circulatory support saves lives -- three years' experience of the newly established assist device program at Semmelweis University, Budapest, Hungary].

Fazekas L, Sax B, Hartyánszky I, Pólos M, Horkay F, Varga T, Rácz K, Németh E, Székely A, Paulovich E, Heltai K, Zima E, Szabolcs Z, Merkely B.

Orv Hetil. 2015 Mar 29;156(13):521-7. doi: 10.1556/OH.2015.30115. Hungarian.

PMID:
25796280
15.

The European Respiratory Society plans its future: the 2013-2018 strategic plan.

Migliori GB, Rabe KF, Bel E, Elliott M, Gaga M, Holgate ST, Joos G, Burrieza FM, Sax B, Sculier JP, Simonds AK, Blasi F, Barnes PJ.

Eur Respir J. 2014 Apr;43(4):927-32. doi: 10.1183/09031936.00221613. No abstract available.

16.

Characterization of pericardial and plasma ghrelin levels in patients with ischemic and non-ischemic heart disease.

Sax B, Merkely B, Túri K, Nagy A, Ahres A, Hartyánszky I, Hüttl T, Szabolcs Z, Cseh K, Kékesi V.

Regul Pept. 2013 Sep 10;186:131-6. doi: 10.1016/j.regpep.2013.08.003. Epub 2013 Aug 28.

PMID:
23994275
17.

Left ventricular untwisting in athlete's heart: key role in early diastolic filling?

Kovács A, Apor A, Nagy A, Vágó H, Tóth A, Nagy AI, Kováts T, Sax B, Széplaki G, Becker D, Merkely B.

Int J Sports Med. 2014 Mar;35(3):259-64. doi: 10.1055/s-0033-1349076. Epub 2013 Jul 30.

PMID:
23900895
18.

Coronary vasoconstrictor effect of ghrelin is not mediated by growth hormone secretagogue receptor 1a type in dogs.

Sax B, Nadasy GL, Turi K, Hirschberg K, Furjesz D, Nagy A, Merkely B, Szabo G, Monos E, Kekesi V.

Peptides. 2011 Feb;32(2):362-7. doi: 10.1016/j.peptides.2010.11.020. Epub 2010 Nov 30.

PMID:
21126551
19.

Comparison of elimination and cardiovascular effects of adenine nucleosides administered intrapericardially or intravenously in anesthetized dog.

Nagy A, Sax B, Entz L Jr, Barát E, Toma I, Becker D, Merkely B, Kékesi V.

J Cardiovasc Pharmacol. 2009 Oct;54(4):341-7. doi: 10.1097/FJC.0b013e3181b7674b.

PMID:
19687746
20.

Intrapericardial angiotensin II stimulates endothelin-1 and atrial natriuretic peptide formation of the in situ dog heart.

Toma I, Sax B, Nagy A, Entz L Jr, Rusvai M, Juhász-Nagy A, Kékesi V.

Exp Biol Med (Maywood). 2006 Jun;231(6):847-51.

PMID:
16741010
21.

The aspartimide problem in Fmoc-based SPPS. Part II.

Mergler M, Dick F, Sax B, Stähelin C, Vorherr T.

J Pept Sci. 2003 Aug;9(8):518-26.

PMID:
12952393
22.

The aspartimide problem in Fmoc-based SPPS. Part I.

Mergler M, Dick F, Sax B, Weiler P, Vorherr T.

J Pept Sci. 2003 Jan;9(1):36-46.

PMID:
12587881
23.

Synthesis and application of Fmoc-His(3-Bum)-OH.

Mergler M, Dick F, Sax B, Schwindling J, Vorherr TH.

J Pept Sci. 2001 Sep;7(9):502-10.

PMID:
11587189
24.

[Positive presentation of a localized neuroblastoma in skeletal scintigraphy].

Sax B, Samnick S, Kirsch CM.

Nuklearmedizin. 2000;39(4):N51-3. German. No abstract available.

PMID:
10919165
25.

Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.

Samnick S, Bader JB, Müller M, Chapot C, Richter S, Schaefer A, Sax B, Kirsch CM.

Nucl Med Commun. 1999 Jun;20(6):537-45.

PMID:
10451866
26.

[Pregnancy and hyperthyroidism].

Sax B, Kirsch CM.

Z Geburtshilfe Neonatol. 1999 Jan-Feb;203(1):29-35. Review. German.

PMID:
10427670
27.
28.
29.

HHS and Justice pass the buck on fraud violations.

Sax BM.

Healthspan. 1986 Mar;3(3):24-7. No abstract available.

PMID:
10300723
30.

Joint ventures and illegal remuneration: the pressure is growing.

Sax BM.

Healthc Financ Manage. 1986 Mar;40(3):38-41.

PMID:
10275451
31.

HHS begins to monitor recent joint ventures.

Sax BM.

Hospitals. 1985 Nov 1;59(21):87, 90. No abstract available.

PMID:
3902612
32.

New challenge: civil RICO and the health care field.

Sax BM.

Health Law Vigil. 1985 Sep 20;8(19):19-21. No abstract available.

PMID:
10272718
33.

Peer review organizations may increase Inspector General's sanction activity.

Sax BM.

Health Law Vigil. 1985 Sep 6;8(18):15-7. No abstract available.

PMID:
10300320
34.

Cataract surgery and intraocular lenses: crackdown on fraud, waste, and abuse.

Sax BM.

Health Law Vigil. 1985 Aug 23;8(17):17-9. No abstract available.

PMID:
10317641
35.

Government wins first decision under Civil Monetary Penalties Law.

Sax BM.

Health Law Vigil. 1985 Apr 5;8(7):3-4. No abstract available.

PMID:
10300005
36.

Fiscal integrity and the Civil Monetary Penalties Law.

Sax BM.

Health Law Vigil. 1985 Mar 8;8(5):18-20. No abstract available.

PMID:
10299934
38.

The use of PH 203 (panthesine hydergine) in thrombo-embolic diseases in obstetrics and gynaecology.

GANS B, ECKERLING B, SAX B.

S Afr Med J. 1959 Aug 22;33:707-9. No abstract available.

PMID:
13826317

Supplemental Content

Support Center